BFEC
NTUS

Benjamin F. Edwards & Company’s Natus Medical Inc NTUS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,335
Closed -$77K – 1934
2019
Q4 		$77K Hold
2,335
– – 0.01% 853
2019
Q3 		$74K Sell
2,335
-200
-8% -$5.83K 0.01% 817
2019
Q2 		$65K Hold
2,535
– – 0.01% 830
2019
Q1 		$64K Buy
2,535
+100
+4% +$2.98K 0.01% 813
2018
Q4 		$83K Sell
2,435
-355
-13% -$11.5K 0.01% 709
2018
Q3 		$99K Sell
2,790
-470
-14% -$16.6K 0.01% 676
2018
Q2 		$112K Sell
3,260
-450
-12% -$15.8K 0.01% 647
2018
Q1 		$125K Buy
3,710
+1,246
+51% +$39.4K 0.01% 622
2017
Q4 		$94K Sell
2,464
-268
-10% -$10.7K 0.01% 664
2017
Q3 		$102K Buy
2,732
+2,607
+2,086% +$92K 0.01% 600
2017
Q2 		$5K Buy
+125
New +$4.52K ﹤0.01% 1254

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Benjamin F. Edwards & Company's NTUS Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of Natus Medical Inc (NTUS) in Q1 2020, closing a stake of 2,335 shares — an estimated $77K sold.

Benjamin F. Edwards & Company first reported a position in NTUS in Q2 2017 and held it in 11 quarters. The position peaked at $125K in Q1 2018. 166 funds tracked by Wall St. Rank hold NTUS as of Q1 2020.

  • Benjamin F. Edwards & Company reported no remaining Natus Medical Inc position as of Q1 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 2,335 Natus Medical Inc shares in Q1 2020, an estimated $77K.
  • Benjamin F. Edwards & Company first reported a position in Natus Medical Inc in Q2 2017 and held it in 11 quarters.
  • Benjamin F. Edwards & Company's Natus Medical Inc position peaked at $125K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.